main-image-lti-FPO

Lysosomal Therapeutics, Inc.

Lysosomal Therapeutics, Inc. is developing novel therapies for severe neurodegenerative diseases including Gaucher’s and Parkinson’s.

Headquarters Cambridge, MA
Website www.lysosomaltx.com​
Pipeline Preclinical